Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Study completedNCT00330382What this trial is testingBowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral LeukoplakiaWho this might be right forLip and Oral Cavity CancerOral LeukoplakiaOropharyngeal Cancer+1 more National Cancer Institute (NCI) 325
Testing effectiveness (Phase 2)Study completedNCT03370276What this trial is testingCetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more H. Lee Moffitt Cancer Center and Research Institute 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618What this trial is testingPreoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell CarcinomaWho this might be right forOral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more Shanghai Zhongshan Hospital
Not applicableUnknownNCT00918710What this trial is testingHuman Papillomavirus and Oropharynx CarcinomaWho this might be right forOropharyngeal Neoplasms Assistance Publique - Hôpitaux de Paris 362
Not applicableStudy completedNCT00693550What this trial is testingContact Allergies to Dental Metal as a Possible Risk Factor for Oral CancerWho this might be right forHead and Neck Cancer Mayo Clinic 115
Testing effectiveness (Phase 2)Ended earlyNCT02196168What this trial is testingCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more National Cancer Institute (NCI) 6
Large-scale testing (Phase 3)Study completedNCT00964977What this trial is testingEffectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.Who this might be right forOropharyngeal CancerOral CancerLymph Node Metastasis Johannes Gutenberg University Mainz 209
Not applicableStudy completedNCT03377270What this trial is testingClinical Impact of Respiratory-Swallow Training on Refractory Dysphagia in Oropharyngeal Head and Neck CancerWho this might be right forHead and Neck CancerDysphagia VA Office of Research and Development 49
Not applicableStudy completedNCT03838601What this trial is testingRole of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2Who this might be right forHead and Neck Squamous Cell Carcinoma University Health Network, Toronto 30
Testing effectiveness (Phase 2)Ended earlyNCT00720083What this trial is testingChemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 34
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Not applicableLooking for participantsNCT06642324What this trial is testingHuman Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell CarcinomasWho this might be right forHead Neck CancerOropharyngeal Neoplasms Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 550
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableStudy completedNCT06314711What this trial is testingEx Vivo 3D-ultrasound for Oropharyngeal CancerWho this might be right forOropharyngeal Squamous Cell Carcinoma Rigshospitalet, Denmark 15
Not applicableUnknownNCT00415298What this trial is testingAP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer University of California, San Diego 12
Not applicableActive Not RecruitingNCT04874493What this trial is testingPatient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal CancerWho this might be right forOropharyngeal Carcinoma M.D. Anderson Cancer Center 77
Large-scale testing (Phase 3)Study completedNCT00004234What this trial is testingOral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxWho this might be right forHead and Neck CancerOral Complications NCIC Clinical Trials Group
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)